These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34221460)

  • 21. Pharmacovigilance in Russia: current state of affairs, challenges, and prospects.
    Gildeeva G; Belostotsky A
    Curr Med Res Opin; 2017 Dec; 33(12):2161-2166. PubMed ID: 28562116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning on adverse drug reactions for pharmacovigilance.
    Lee CY; Chen YP
    Drug Discov Today; 2019 Jul; 24(7):1332-1343. PubMed ID: 30876845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and Implementation of a Computerized Management System for Adverse Drug Reactions at the Sourô SANOU University Hospital (CHUSS) in Bobo-Dioulasso, Burkina Faso.
    Traore ASH; Barro SG; Fofana S; Sombie I; Semde R; De Vriese C; Ilboudo D; Staccini P
    Stud Health Technol Inform; 2022 Jan; 289():144-147. PubMed ID: 35062112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021).
    Mhaidat NM; Alshogran OY; Altawalbeh SM; Jaber JM; Banat HA; Ahmad DS; Alabsi W
    Expert Opin Drug Saf; 2023; 22(10):957-965. PubMed ID: 37293991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The position and importance of pharmacovigilance in the Czech Republic and in the world].
    Zatovkaňuková P; Slíva J
    Vnitr Lek; 2022; 68(E-4):10-15. PubMed ID: 36220372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Importance and specificity of pharmacovigilance in the pediatric population].
    Rodieux F; Ing-Lorenzini K; Rollason V
    Rev Med Suisse; 2019 Apr; 15(645):743-747. PubMed ID: 30942973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar.
    Al Hail M; Elkassem W; Hamad A; Abdulrouf P; Thomas B; Stewart D
    Int J Clin Pharm; 2018 Aug; 40(4):769-774. PubMed ID: 29616393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social media and pharmacovigilance: A review of the opportunities and challenges.
    Sloane R; Osanlou O; Lewis D; Bollegala D; Maskell S; Pirmohamed M
    Br J Clin Pharmacol; 2015 Oct; 80(4):910-20. PubMed ID: 26147850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the impact of pharmacovigilance activities, challenging but important.
    van Hunsel F; Gardarsdottir H; de Boer A; Kant A
    Br J Clin Pharmacol; 2019 Oct; 85(10):2235-2237. PubMed ID: 31368147
    [No Abstract]   [Full Text] [Related]  

  • 30. Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability.
    Pinheiro LC; Kurz X
    Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1308-1310. PubMed ID: 35959980
    [No Abstract]   [Full Text] [Related]  

  • 31. Visualising Patterns Associated with Adverse Drug Reactions in French Forums.
    Allam N; Audeh B; Jaulent MC; Bousquet C
    Stud Health Technol Inform; 2021 May; 281():1110-1111. PubMed ID: 34042861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The history of pharmacovigilance.
    Caron J; Rochoy M; Gaboriau L; Gautier S
    Therapie; 2016 Apr; 71(2):129-34. PubMed ID: 27080830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb.
    van Hunsel FPAM; van der Kooi D; van de Koppel S; Kroes BH; Woerdenbag HJ
    Drug Saf; 2022 Jun; 45(6):651-661. PubMed ID: 35608783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinemeducation in clinical pharmacology: using cinema to help students learn about pharmacovigilance and adverse drug reactions.
    Cambra-Badii I; Francés ML; Videla S; Farré M; Montané E; Blázquez F; Baños JE
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1653-1658. PubMed ID: 32886177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country.
    Nguyen KD; Nguyen PT; Nguyen HA; Roussin A; Montastruc JL; Bagheri H; Olsson S
    Drug Saf; 2018 Feb; 41(2):151-159. PubMed ID: 28975584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-Drug Interactions: A Pharmacovigilance Road Less Traveled.
    Price J
    Clin Ther; 2023 Feb; 45(2):94-98. PubMed ID: 36641261
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data.
    Grandvuillemin A; Fresse A; Cholle C; Yamani S; Dautriche A;
    Therapie; 2020; 75(4):385-387. PubMed ID: 32402475
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database.
    Campillo JT; Faillie JL
    Therapie; 2022; 77(6):747-749. PubMed ID: 35606189
    [No Abstract]   [Full Text] [Related]  

  • 39. Belgian community pharmacists' pharmacovigilance perspective and practice.
    De Meestere D; Saevels J
    Res Social Adm Pharm; 2019 Dec; 15(12):1446-1452. PubMed ID: 30733138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions.
    Neubert A; Dormann H; Prokosch HU; Bürkle T; Rascher W; Sojer R; Brune K; Criegee-Rieck M
    Br J Clin Pharmacol; 2013 Sep; 76 Suppl 1(Suppl 1):69-77. PubMed ID: 23586589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.